retatrutide phase 3 trial Shows 28.3% Weight Loss in Obesity 🚨 TRIUMPH-1: #retatrutide topline data🚨

Moeisha was very kind and informative while I determined if this was the right plan for me

FDA-approved GLP-1/GIP medications for weight loss and type 2 diabetes, including Ozempic, Wegovy, Zepbound, and Mounjaro, may also be eligible for coverage

While the dashboard was referenced in a number of media reports over the last couple weeks, wed like to especially thank Mike Erman at Reuters, Ed Silverman at STAT News, Khristopher Brooks at CBS News, Noah Manskar at New York Post, Kate Ashford at Investopedia, and Darrel Rowland at Columbus Dispatch for highlighting the tool, as well as correctly providing some of the nuances at play in the marketplace

Despite the effectiveness of these medications, this risk warrants a serious look at their safety profile

If traveling by air, keep tirzepatide in your carry-on luggage rather than checked baggage to avoid freezing temperatures in the cargo hold

Under the MHRA's 'borderline products' guidance, transdermal patches designed to deliver active substances systemically would typically be classified as medicines requiring marketing authorisation